🇺🇸

US SEC Filing Intelligence

· daily

Contract Deobligations Alert — July 04, 2026

The two civilian contracts awarded between June 30 and July 1, 2026, total $684.3 million in obligations, with zero defense-related awards. The dominant theme is General Services Administration (GSA) investment in border infrastructure, led by a $464.3 million firm-fixed-price contract to Davis Constructors & Engineers for the Alcan Land Port of Entry modernization in Alaska, signaling sustained federal spending on land port modernization. The highest-conviction signal is V3GATE’s $219.9 million Department of Veterans Affairs (VA) delivery order for Salesforce licenses and AI-driven support services, which carries a potential value of $1.64 billion if all options are exercised, reflecting accelerating civilian-agency AI adoption. Key risk includes execution pressure on V3GATE under the firm-fixed-price structure for AI services, and potential delays at the Alcan port project given Alaska’s construction season and logistics constraints.

2 total filings
· daily

Contract Option Exercises — July 04, 2026

Over the July 4, 2026 period, two contract option exercises totaling $684.3 million were identified, exclusively civilian in nature (0% defense-related). The dominant theme is federal infrastructure modernization, split between border port construction and AI-enabled IT services. The highest-conviction signal is a $219.9 million VA award to V3GATE LLC for Salesforce and AI support, reflecting accelerating civilian agency AI procurement. However, investor bearishness should focus on execution risk: V3GATE must deliver AI services on fixed-price terms, and Davis Constructors faces remote Alaska project delays. No equity exposure exists to Davis (private), but V3GATE's award signals potential for publicly traded AI/IT services firms like Booz Allen Hamilton or CACI International in civilian agency budgets.

2 total filings
· daily

Federal IT & Cybersecurity Contracts — July 04, 2026

This digest covers a single, high-materiality civilian contract awarded by the Department of Veterans Affairs (VA) to V3GATE, LLC, a Service Disabled Veteran Owned Small Business (SDVOSB), valued at $219.9 million in base obligations with a potential ceiling of $1.64 billion. The contract is entirely civilian, reflecting the VA's accelerating investment in AI-driven IT modernization and cloud-based SaaS platforms. The highest-conviction signal is the strong alignment with federal set-aside policy and the AI theme, though the firm-fixed-price structure introduces execution risk. Key watch items include V3GATE's delivery performance and the VA's budget trajectory for option exercise.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — July 04, 2026

The two contracts awarded between July 4, 2026, and July 4, 2026, total $684.3 million in obligations, with zero defense-related awards, underscoring a civilian-heavy procurement week led by the General Services Administration and the Department of Veterans Affairs. The dominant theme is federal infrastructure modernization, with a $464.3 million GSA contract to Davis Constructors for border port expansion and a $219.9 million VA award to V3GATE for AI-driven Salesforce services. The highest-conviction signal is the V3GATE award, which is bullish due to its SDVOSB set-aside status and potential value up to $1.64 billion if all options are exercised. A key risk is the firm-fixed-price structure on both contracts, which could compress margins if cost overruns occur, particularly for V3GATE's AI services.

2 total filings
· daily

High-Value Federal Grants ($5M+) — July 04, 2026

The two contracts awarded between June 30 and July 1, 2026, total $684.3 million, with zero defense-related awards and a 100% civilian agency split. The dominant theme is federal infrastructure and IT modernization, led by a $464.3 million GSA contract to Davis Constructors & Engineers for a land port of entry in Alaska and a $219.9 million VA delivery order to V3GATE for Salesforce and AI-driven support services. The highest-conviction signal is the V3GATE award, which carries a potential value of $1.64 billion if all options are exercised, reflecting strong government demand for AI-enhanced IT services. A key risk is the fixed-price structure on both contracts, which could pressure margins if execution costs overrun, particularly for the construction project in remote Alaska.

2 total filings
· daily

General Federal Contracts — July 04, 2026

The two civilian contracts totaling $684.3 million reveal a bifurcated federal investment story: border infrastructure modernization via a $464.3 million GSA award to Davis Constructors for the Alcan Port of Entry, and a $219.9 million VA IT modernization award to V3GATE for AI-driven Salesforce services. The dominant theme is civilian agency spending on physical and digital infrastructure, with zero defense exposure. The highest-conviction signal is V3GATE's bullish award, reflecting strong policy tailwinds for SDVOSB set-asides and AI adoption in government IT, though its fixed-price structure introduces execution risk. Key watch items include potential delays at the Alaska border project and the VA's budget trajectory for AI option exercises.

2 total filings
· daily

Federal Construction & Infrastructure Contracts — July 03, 2026

This digest covers a single, high-value $491.8 million civilian contract awarded by the CDC (HHS) to MANHATTAN TORCON A JOINT VENTURE for construction of a high-containment laboratory in Atlanta, GA. The contract is defense-related only in the sense of biodefense alignment, but is purely civilian in execution. The highest-conviction signal is neutral: the award signals sustained federal investment in biodefense infrastructure, but the fixed-price structure and joint venture structure introduce execution risk and opacity for investors. Key watch items include potential cost overruns on the fixed-price contract and the lack of a clear publicly traded parent entity for revenue attribution.

1 total filings
· daily

New Federal Contractors — July 03, 2026

This digest covers $5.88 billion in new federal obligations from July 3, 2026, with only 1 of 5 contracts defense-related, signaling a civilian-heavy procurement week dominated by energy security and health infrastructure. The highest-conviction signal is a $900 million DOE award to AMERICAN CENTRIFUGE OPERATING, LLC for domestic HALEU production, aligning with bipartisan nuclear fuel policy and offering a predictable $90M annual revenue stream. A $3.52B HHS contract to RAPID DEPLOYMENT INC is the largest by value but lacks pricing and competitive detail, introducing opacity risk. Key risks include execution pressure on small businesses under fixed-price contracts and near-term contract expirations for KBR and Raytheon at NASA and NOAA, respectively. Investors should watch for follow-on HALEU awards and CDC lab construction progress as sector catalysts.

5 total filings
· daily

Significant Contract Modifications ($10M+) — July 03, 2026

The five contracts analyzed, totaling $5.88 billion, are overwhelmingly civilian in nature (4 of 5), with only one defense-related award. The dominant theme is federal investment in energy security and biodefense infrastructure, led by a $3.52B HHS award to RAPID DEPLOYMENT INC and a $900M DOE contract to AMERICAN CENTRIFUGE OPERATING for domestic HALEU production. The highest-conviction signal is the bullish long-term revenue stream for AMERICAN CENTRIFUGE OPERATING, averaging $90M annually over 10 years, tied to U.S. nuclear fuel supply policy. Key risks include execution risk on the fixed-price CDC lab construction contract ($491.8M) for MANHATTAN TORCON A JOINT VENTURE and the impending expiration of KBR's NASA support contract in November 2024, which poses renewal uncertainty.

5 total filings
· daily

Contract Deobligations Alert — July 03, 2026

This digest covers $5.88 billion in federal obligations from July 3, 2026, with only 1 of 5 contracts being defense-related, signaling a strong civilian agency spending tilt. The dominant theme is energy security and infrastructure, led by a $900 million Department of Energy award to AMERICAN CENTRIFUGE OPERATING for domestic HALEU production, and a $491.8 million CDC lab construction contract to MANHATTAN TORCON. The highest-conviction signal is the bullish, policy-aligned HALEU contract, which provides a predictable $90 million annual revenue stream over 10 years. Key risks include execution risk on the fixed-price CDC lab build and the impending expiration of KBR's $364.7 million NASA contract in November 2024. The digest reveals a shift toward civilian energy and biodefense priorities, with limited direct defense exposure.

5 total filings
· daily

Contract Option Exercises — July 03, 2026

This digest covers $5.88 billion in contract option exercises from July 3, 2026, with only 1 of 5 contracts defense-related, signaling a civilian-heavy procurement week dominated by the Department of Health and Human Services (HHS). The highest-conviction signal is a $3.52B sole-source award to RAPID DEPLOYMENT INC from HHS, representing 60% of total value, though its opaque details (unknown revenue, pricing, competition) create significant information risk. A $900M DOE contract to AMERICAN CENTRIFUGE OPERATING, LLC for domestic HALEU production offers a clear long-term growth narrative tied to energy security policy, but the firm-fixed-price structure poses execution risk for a small business. Key risk: the $606.7M Raytheon (RTX) NOAA contract has only $10.2M outlayed, suggesting minimal near-term revenue recognition despite its headline size.

5 total filings
· daily

All HHS Contracts — July 03, 2026

This digest covers two HHS contracts totaling $4.01 billion, with a dominant $3.52 billion defense-related award to RAPID DEPLOYMENT INC that accounts for 87.7% of the total obligation, signaling a major, likely urgent national security-linked procurement within the civilian health agency. The second contract, a $491.8 million firm-fixed-price award to MANHATTAN TORCON A JOINT VENTURE for CDC high-containment lab construction, reflects sustained federal investment in biodefense infrastructure. The highest-conviction signal is the sheer scale of the RAPID DEPLOYMENT INC award, which dwarfs typical HHS contracts and suggests a critical, possibly sole-source or emergency-driven mission. Key risks include the unknown competitive dynamics and pricing structure of the RAPID DEPLOYMENT INC contract, and the high execution risk of the fixed-price lab construction project, which could lead to cost overruns or margin pressure for the joint venture's parent entities.

2 total filings
· daily

All DOE Contracts — July 03, 2026

The single contract analyzed, a $900 million firm fixed-price delivery order from the Department of Energy to AMERICAN CENTRIFUGE OPERATING, LLC for domestic HALEU production, represents a fully civilian allocation with zero defense-related awards. The dominant sector theme is U.S. nuclear fuel supply chain reshoring, supported by a high-conviction bullish signal (8/10). Key risks include the fixed-price execution burden on a small business recipient and the long 10-year performance period amid potential policy shifts. Investors should monitor AMERICAN CENTRIFUGE’s ability to manage cost overruns on a $90 million annual contract, as any performance failure could delay DOE’s HALEU goals.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — July 03, 2026

The five mega-contracts totaling $5.88 billion reveal a predominantly civilian federal spending pattern, with only 1 of 5 contracts defense-related (HHS/CDC, though defense-funded). The dominant theme is energy security and biodefense infrastructure, led by a $3.52B HHS award to RAPID DEPLOYMENT INC and a $900M DOE contract to AMERICAN CENTRIFUGE OPERATING for domestic HALEU production. The highest-conviction signal is the long-term, policy-aligned revenue stream for AMERICAN CENTRIFUGE, though its fixed-price structure and small-business status introduce execution risk. A key risk is the $491.8M CDC lab contract to MANHATTAN TORCON JV, which carries high fixed-price execution risk on a complex construction project. Overall, the digest points to growing civilian agency investment in strategic domestic capabilities (nuclear fuel, biodefense labs) rather than traditional defense procurement.

5 total filings
· daily

High-Value Federal Grants ($5M+) — July 03, 2026

This digest of 5 high-value federal grants ($5.9B total) reveals a heavy civilian skew (4 of 5 contracts from HHS, DOE, Commerce, NASA), with only 1 defense-related award (RAPID DEPLOYMENT INC at $3.5B). The dominant theme is U.S. energy security and infrastructure: DOE's $900M HALEU contract to AMERICAN CENTRIFUGE OPERATING signals a multi-year push for domestic nuclear fuel supply, while CDC's $492M high-containment lab build-out underscores biodefense infrastructure spending. The highest-conviction bullish signal is the American Centrifuge contract due to its policy alignment and predictable revenue stream, but it carries medium execution risk from firm-fixed pricing. Key watch item: KBR's $365M NASA contract expires November 2024, posing renewal risk for the contractor.

5 total filings
· daily

DOE Energy Grants — July 03, 2026

This digest covers a single, high-conviction civilian contract: a $900 million firm fixed-price delivery order from the Department of Energy to AMERICAN CENTRIFUGE OPERATING, LLC for domestic HALEU production over 10 years. The aggregate $900 million is entirely civilian, with no defense-related awards. The dominant theme is U.S. energy security and nuclear fuel supply chain resilience. The highest-conviction signal is the long-term, $90 million annual revenue stream for a small business, though the firm fixed-price structure introduces material execution risk. Key watch items include the company's ability to manage fixed-price performance risk and potential follow-on contracts in the domestic nuclear fuel market.

1 total filings
· daily

All NASA Contracts — July 03, 2026

The sole NASA contract analyzed for July 3, 2026, is a $364.7 million cost-plus-fixed-fee award to KBR WYLE Services, LLC (KBR, Inc.) from NASA Ames Research Center for R&D and project management support. This is a civilian agency contract with no defense exposure, representing a long-term, stable revenue stream for KBR but with limited upside due to the cost-plus pricing structure. The highest-conviction signal is neutral, as the contract is nearing its November 2024 end date, posing renewal risk despite high funding certainty. A key watch item is KBR's ability to secure a follow-on award, which will be critical for maintaining its NASA revenue stream.

1 total filings
· daily

Global High-Priority Regulatory Events — July 03, 2026

The July 3, 2026, digest reveals a market bifurcated between aggressive corporate action (M&A, capital restructuring) and deepening distress in specific sectors. A clear theme is the consolidation of strategic capabilities, with several large-cap companies (Samvardhana Motherson, Prestige Estates, Inventurus) executing multi-jurisdictional acquisitions to expand global footprints, though many financial terms remain undisclosed. Concurrently, the Indian real estate and entertainment sectors show acute stress: Mediaone Global Entertainment faces a high-materiality SEBI fraud probe alleging financial fabrication from a near-zero revenue base, while religious infrastructure defaults (Simbhaoli Sugars) and repeat insolvency filings (BIL Vyapar, Spectra Industries) underscore a rising tide of credit events. Notably, the capital restructuring at Sikozy Realtors (90% share capital reduction) is a non-cash balance-sheet repair that does not signal new insolvency. Overall, this is a digest of 'haves' (acquirers with cash and vision) and 'have-nots' (companies in CIRP or under regulatory fire), suggesting investors should favor companies with demonstrated cash flows and disclosed financials over those reliant on opaque turnaround narratives.

28 high priority 28 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 03, 2026

The overnight filing period reveals a significant cluster of insider selling activity, particularly concentrated in CoreWeave, Spyre Therapeutics, and ASP Isotopes, raising caution flags for these names. A major capital return event is unfolding at Janus Henderson, with two directors disposing of over $50M in stock back to the issuer, signaling a potential large-scale buyback or restructuring. The most impactful corporate action is the announced merger between Passage BIO and Remix Therapeutics, creating a new entity (RMTX) and offering a contingent value right to existing PASG shareholders, which represents a high-conviction catalyst. Period-over-period trends are limited in this filing set, but the insider trading patterns show a clear bearish tilt, with 14 negative transactions versus only 1 positive purchase. The data suggests a defensive posture among corporate insiders in growth and biotech names, while financial and utility sectors show routine, non-alarming insider activity. Overall, the digest points to heightened risk in high-growth names and a potential opportunity in the Passage BIO/Remix merger arbitrage.

48 high priority 2 medium 50 total filings